Revvity (RVTY) FCF Payout Ratio Growth (3y) (2012 - 2026)
Revvity (RVTY) FCF Payout Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -0.94% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.90% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.78% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -10.55% |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 40.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 40.66% |
| Apr 5, 2026 | -24.97% |
| Dec 28, 2025 | 55.46% |
| Mar 30, 2025 | 32.85% |
| Sep 29, 2024 | 28.11% |
| Jun 30, 2024 | 22.60% |
| Mar 31, 2024 | 56.38% |
| Dec 31, 2023 | 13.06% |
| Oct 1, 2023 | -79.30% |
| Jul 2, 2023 | -41.98% |
| Apr 2, 2023 | -3.94% |
| Jan 1, 2023 | -39.09% |
| Apr 3, 2022 | 27.99% |
| Oct 3, 2021 | -34.46% |
| Jul 4, 2021 | -40.36% |
| Apr 4, 2021 | 27.69% |
| Jan 3, 2021 | -38.14% |
| Oct 4, 2020 | -34.68% |
| Jul 5, 2020 | -29.21% |
| Apr 5, 2020 | 6.96% |